Analysis of Gastrointestinal and Genitourinary Morbidity of Postoperative Radiotherapy for Pathologic T3 Disease or Positive Surgical Margins After Radical Prostatectomy Using National Cancer Institute Expanded Common Toxicity Criteria

International Journal of Radiation Oncology Biology Physics

Volumn 72, Issue 4, 2008, Pages 989-995

  Choo, Richard ^a   Pearse, Maria ^b   Danjoux, Cyril ^c   Gardner, Sandra ^c   Morton, Gerard ^c   Szumacher, Ewa ^c   Loblaw, D Andrew ^c   Cheung, Patrick ^c  

^a MAYO CLINIC   (United States)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

Author keywords

Positive surgical margin; Postoperative radiotherapy; Prostate cancer; Stage pT3; Toxicity

Indexed keywords

PINCH EFFECT; RADIOTHERAPY; REGRESSION ANALYSIS; TURBULENT FLOW;

ACUTE GU TOXICITIES; ADJUSTING; ANDROGEN SUPPRESSIONS; CUMULATIVE INCIDENCE METHODS; GENITOURINARY TOXICITIES; GI TOXICITIES; GREAT-ER; GU TOXICITIES; NATIONAL CANCER INSTITUTES; PATIENT AGES; PHASE II; POSITIVE SURGICAL MARGIN; POSTOPERATIVE RADIOTHERAPIES; POSTOPERATIVE RADIOTHERAPY; PREDICTIVE FACTORS; PROSTATE CANCER; RADICAL PROSTATECTOMIES;

TOXICITY;

ADULT; AGED; ANDROGEN THERAPY; ARTICLE; CANCER CENTER; CONTROLLED STUDY; GASTROINTESTINAL TOXICITY; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NEPHROTOXICITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSTATE CANCER; PROSTATECTOMY;

FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MALE UROGENITAL DISEASES; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT;

EID: 52949135530     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.02.044     Document Type: Article

References (8)

1. Bolla M., van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: A randomised controlled trial (EORTC trial 22911). Lancet 366 (2005) 572-578
2. Thompson I.M., Tangen C., Paradelo J., et al. Adjuvant radiotherapy for pathologically advanced prostate cancer. JAMA 296 (2006) 2329-2335
3. Wiegel T., Bottke D., Willich N., et al. Phase III results of adjuvant radiotherapy (RT) versus "wait and see" (WS) in patients with pT3 prostate cancer following radical prostatectomy (RP) (ARO 96-02/AUO AP 09/95). [Abstract]. J Clin Oncol 23 Suppl. 16S (2005) 381s
4. Choo R., Pearce A., Danjoux C., et al. Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for pT3 and/or positive resection margin following radical prostatectomy. Eur Urol 52 (2007) 1645-1652
5. Pintilie M. Competing risks: A practical perspective (2006), John Wiley & Sons, New York
6. Kalbfleisch J.D., and Prentice R.L. The statistical analysis of failure time data (1980), John Wiley & Sons, New York
7. Van Cangh P.J., Richard F., Lorge F., et al. Adjuvant radiation therapy does not cause urinary incontinence after radical prostatectomy: Results of a prospective randomized study. J Urol 159 (1998) 164-166
8. Feng M., Hanlon A.L., Pisansky T.M., et al. Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1417-1423